维莫德吉（Erivedge）用于治疗晚期基底细胞癌。
Vismodegib (erivedge) for advanced Basal cell carcinoma.
作者信息
Fellner Chris
出版信息
P T. 2012 Dec;37(12):670-82.
Abstract
Vismodegib (Erivedge) for advanced basal cell carcinoma.
摘要
维莫德吉（Erivedge）用于治疗晚期基底细胞癌。
相似文献
1
Vismodegib (erivedge) for advanced Basal cell carcinoma.维莫德吉（Erivedge）用于治疗晚期基底细胞癌。
P T. 2012 Dec;37(12):670-82.
2
Vismodegib (ERIVEDGE) pregnancy prevention programme: assessment of risk awareness.维莫德吉（ERIVEDGE）妊娠预防计划：风险意识评估。
J Dermatolog Treat. 2022 Feb;33(1):466-472. doi: 10.1080/09546634.2020.1770166. Epub 2020 Jun 1.
3
Vismodegib (ERIVEDGE°) In basal cell carcinoma: too many unknowns.维莫德吉（ERIVEDGE°）用于基底细胞癌：未知因素过多。
Prescrire Int. 2015 Jan;24(156):11-4.
4
Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma.维莫德吉与刺猬通路：基底细胞癌的一种新疗法。
Clin Ther. 2012 Oct;34(10):2039-50. doi: 10.1016/j.clinthera.2012.08.011. Epub 2012 Oct 1.
5
Efficacy of Vismodegib (Erivedge) for Basal Cell Carcinoma Involving the Orbit and Periocular Area.维莫德吉（Erivedge）治疗累及眼眶及眼周区域的基底细胞癌的疗效
Ophthalmic Plast Reconstr Surg. 2015 Nov-Dec;31(6):463-6. doi: 10.1097/IOP.0000000000000388.
6
Non-surgical Management of Locally Advanced Basal Cell Carcinoma of the Upper Extremity With Vismodegib.维莫德吉对上肢局部晚期基底细胞癌的非手术治疗
Cureus. 2022 Aug 27;14(8):e28479. doi: 10.7759/cureus.28479. eCollection 2022 Aug.
7
Pathologic complete response with radiation and vismodegib in a patient with advanced basal cell carcinoma: A case report.晚期基底细胞癌患者经放疗和维莫德吉治疗后达到病理完全缓解：一例报告
Mol Clin Oncol. 2021 Mar;14(3):46. doi: 10.3892/mco.2021.2208. Epub 2021 Jan 13.
8
Treatment of periocular basal cell carcinoma with neoadjuvant vismodegib.维莫德吉新辅助治疗眼周基底细胞癌
Am J Ophthalmol Case Rep. 2020 May 23;19:100755. doi: 10.1016/j.ajoc.2020.100755. eCollection 2020 Sep.
9
Vismodegib and orbital excision for treating locally advanced basal cell carcinoma.维莫德吉与眼眶切除术治疗局部晚期基底细胞癌。
Int Med Case Rep J. 2018 Jul 31;11:177-179. doi: 10.2147/IMCRJ.S168666. eCollection 2018.
10
Complete remission of advanced, locally invasive basal cell carcinoma with vismodegib.维莫德吉治疗晚期局部侵袭性基底细胞癌获得完全缓解。
Int J Oral Maxillofac Surg. 2020 Sep;49(9):1149-1152. doi: 10.1016/j.ijom.2020.03.006. Epub 2020 Mar 20.
引用本文的文献
1
Therapeutic approaches for targeting the pediatric brain tumor microenvironment.针对小儿脑肿瘤微环境的治疗方法。
Drug Deliv Transl Res. 2025 Apr 21. doi: 10.1007/s13346-025-01839-3.
2
Facial basal cell carcinoma: A retrospective study of 67 cases.面部基底细胞癌：67例回顾性研究。
World J Clin Cases. 2023 Mar 6;11(7):1488-1497. doi: 10.12998/wjcc.v11.i7.1488.
3
Advancements in nanoparticle-based treatment approaches for skin cancer therapy.基于纳米粒子的皮肤癌治疗方法的进展。
Mol Cancer. 2023 Jan 12;22(1):10. doi: 10.1186/s12943-022-01708-4.
4
Therapeutic Strategies Against Cancer Stem Cells in Esophageal Carcinomas.食管癌中针对癌症干细胞的治疗策略
Front Oncol. 2021 Feb 16;10:598957. doi: 10.3389/fonc.2020.598957. eCollection 2020.
5
Understanding Abnormal SMO-SHH Signaling in Autism Spectrum Disorder: Potential Drug Target and Therapeutic Goals.理解自闭症谱系障碍中异常的 SMO-SHH 信号传导：潜在的药物靶点和治疗目标。
Cell Mol Neurobiol. 2022 May;42(4):931-953. doi: 10.1007/s10571-020-01010-1. Epub 2020 Nov 18.
6
Vismodegib as First-Line Treatment of Mutated Sonic Hedgehog Pathway in Adult Medulloblastoma.维莫德吉作为成人髓母细胞瘤中突变的音猬因子信号通路的一线治疗药物。
JCO Precis Oncol. 2020 Apr 30;4. doi: 10.1200/PO.19.00264. eCollection 2020.
7
Clues to primary vismodegib resistance lie in histology and genetics.原发性维莫德吉耐药的线索存在于组织学和遗传学中。
J Clin Pathol. 2020 Oct;73(10):678-680. doi: 10.1136/jclinpath-2020-206448. Epub 2020 Mar 26.
8
Management of keratinocyte carcinoma - Special considerations in the elderly.角质形成细胞癌的管理——老年人的特殊考虑因素
Int J Womens Dermatol. 2019 May 18;5(4):235-245. doi: 10.1016/j.ijwd.2019.05.005. eCollection 2019 Sep.
9
Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain Tumor.塞瑞替尼诱导胰岛素样生长因子驱动的神经上皮脑肿瘤消退。
Int J Mol Sci. 2019 Aug 30;20(17):4267. doi: 10.3390/ijms20174267.
10
Head and neck cutaneous basal cell carcinoma: what should the otorhinolaryngology head and neck surgeon care about?头颈部皮肤基底细胞癌：耳鼻咽喉头颈外科医生应关注哪些方面？
Acta Otorhinolaryngol Ital. 2020 Feb;40(1):5-18. doi: 10.14639/0392-100X-2245. Epub 2019 Jul 31.
本文引用的文献
1
Efficacy and safety of vismodegib in advanced basal-cell carcinoma.维莫德吉治疗晚期基底细胞癌的疗效和安全性。
N Engl J Med. 2012 Jun 7;366(23):2171-9. doi: 10.1056/NEJMoa1113713.
2
Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors.希革替尼（GDC-0449）治疗难治性、局部晚期或转移性实体瘤患者的 I 期临床试验。
Clin Cancer Res. 2011 Apr 15;17(8):2502-11. doi: 10.1158/1078-0432.CCR-10-2745. Epub 2011 Feb 7.
3
Pharmacokinetics of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors: the role of alpha-1-acid glycoprotein binding. hedgehog 通路抑制剂维莫德吉（GDC-0449）在局部晚期或转移性实体瘤患者中的药代动力学：α-1-酸性糖蛋白结合的作用。
Clin Cancer Res. 2011 Apr 15;17(8):2512-20. doi: 10.1158/1078-0432.CCR-10-2736. Epub 2011 Feb 7.
4
Focus on Basal cell carcinoma.关注基底细胞癌。
J Skin Cancer. 2011;2011:328615. doi: 10.1155/2011/328615. Epub 2010 Oct 24.
5
Inhibition of the hedgehog pathway in advanced basal-cell carcinoma.晚期基底细胞癌中刺猬信号通路的抑制作用。
N Engl J Med. 2009 Sep 17;361(12):1164-72. doi: 10.1056/NEJMoa0905360. Epub 2009 Sep 2.
6
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.用刺猬信号通路抑制剂GDC-0449治疗髓母细胞瘤。
N Engl J Med. 2009 Sep 17;361(12):1173-8. doi: 10.1056/NEJMoa0902903. Epub 2009 Sep 2.
7
Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Hedgehog 通路在癌症中的激活机制及其治疗意义。
Trends Pharmacol Sci. 2009 Jun;30(6):303-12. doi: 10.1016/j.tips.2009.03.007. Epub 2009 May 13.
8
Basal cell carcinomas: attack of the hedgehog.基底细胞癌：刺猬信号通路的作用
Nat Rev Cancer. 2008 Oct;8(10):743-54. doi: 10.1038/nrc2503.
9
Guidelines for the management of basal cell carcinoma.基底细胞癌管理指南。
Br J Dermatol. 2008 Jul;159(1):35-48. doi: 10.1111/j.1365-2133.2008.08666.x.
10
Management of nonmelanoma skin cancer in 2007.2007年非黑素瘤皮肤癌的管理
Nat Clin Pract Oncol. 2007 Aug;4(8):462-9. doi: 10.1038/ncponc0883.
Zotero 插件